Syngene International Monday announced appointment of Mahesh Bhalgat as the Chief Operating Officer of the company.
He comes to Syngene from Shantha Biotechnics, a Sanofi company, Syngene International said in a statement.
"Syngene has evolved to be a global scale scientific services provider and Dr Bhalgat's significant expertise in R&D, analytical development, technology transfer, regulatory sciences and quality will further enhance Syngene's position as a global CRO (Contract Research Organisation)," Syngene International CEO Jonathan Hunt said.
Bhalgat has rich experience in diverse areas of biotechnology such as biotherapeutics, vaccines, ag-biotech, and research reagents and has been associated with companies such as Amgen, Monsanto, Celera Genomics, Thermo Fisher, Biological E, the statement said.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)